SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Thyrocare Technologies Ltd

BSE: 539871 NSE: THYROCARE ISIN: INE594H01019
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Thyrocare Technologies Ltd belong to?
Thyrocare Technologies Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Thyrocare Technologies Ltd a good quality company?
Thyrocare Technologies Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Thyrocare Technologies Ltd undervalued or overvalued?
Thyrocare Technologies Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Thyrocare Technologies Ltd a good buy now?
Thyrocare Technologies Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd revenue growth is 20.2% for FY-2025 , which is above its 5 year CAGR of 9.6% , indicating faster growth.
Q.2 Gross Profit margin of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Gross profit margin which is the profit after deduction of direct costs, is 29.4% for FY-2025 , which is in line with its 5 year median of 29.4% , indicating stable margins.
Q.3 Operating Profit Margin of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 27.8% for FY-2025 , which is in line with its 5 year median of 27.8% indicating stable margins.
Q.4 Net Profit Margin of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Net Profit Margin is 13.2% for FY-2025 , is in line with with its 5 year median of 13.2%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 29.4 29.4
Operating Profit Margin 27.8 27.8
Net Profit Margin 13.2 13.2
Q.5 Return on Asset of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Return on Asset is 13.82%, which is in line with its 5 year historical median of 13.82%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Return on equity is 17.04% for FY-2025 , which is in line with its historical median of 17.04%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Return on capital employed is 27.25% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Cash conversion cycle is 10 days, below its historical median of 31 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.05 0.85
ROE 17.04 17.04
ROCE 27.25 27.25
Cash Conversion Cycle 10 days 31 days
Q.9 Debt to Equity ratio of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Thyrocare Technologies Ltd?
Promoters hold 60.92% of the Thyrocare Technologies Ltd, with 100.00% of their stake pledged, indicating high pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Thyrocare Technologies Ltd vs industry peers?
Thyrocare Technologies Ltd revenue CAGR is 9.62% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 687.4 144
Gross Profit 202 8.2
Operating Profit 191 8.4
Net Profit 91 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.05 0.73
ROE 17.04 13.88
ROCE 27.25 17.77
Cash Conversion Cycle (days) 10.24 2

Valuation & price assessment

Q.1 Stock return of Thyrocare Technologies Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 2.65% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - 2.7% 36.4% 59.2%
Q.3 Valuation ratios of Thyrocare Technologies Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 45.4 68.65 79.71
Price to Book 9.35 11.56 3.54
Price to Sales 7.89 11.06 4.37
EV to EBITDA 23.59 29.52 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Metropolis Health.
8. Vijaya Diagnostic
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×